Skip to main content
Top

BioDrugs

Issue 3/2016

Content (8 Articles)

Review Article

Update on Metastatic Uveal Melanoma: Progress and Challenges

Francesco Spagnolo, Virginia Picasso, Laura Spano, Enrica Tanda, Clary Venzano, Paola Queirolo

Open Access Review Article

Assessing the Immunogenicity of Biopharmaceuticals

Carlos Pineda, Gilberto Castañeda Hernández, Ira A. Jacobs, Daniel F. Alvarez, Claudio Carini

Systematic Review

Adalimumab for Moderately to Severely Active Ulcerative Colitis: A Systematic Review and Meta-Analysis

Xinlin Chen, Jiangtao Hou, Yujie Yuan, Chaoyuan Huang, Tianwen Liu, Chuanwei Mo, Haiwen Li, Bin Chen, Qian Xu, Zhengkun Hou, Weiling He, Fengbin Liu

Short Communication

Anagrelide and Mutational Status in Essential Thrombocythemia

Alessandra Iurlo, Daniele Cattaneo, Nicola Orofino, Cristina Bucelli, Sonia Fabris, Agostino Cortelezzi

Short Communication

Comparability of Antibody-Mediated Cell Killing Activity Between a Proposed Biosimilar RTXM83 and the Originator Rituximab

Hector A. Cuello, Valeria I. Segatori, Marina Alberto, Analía Pesce, Daniel F. Alonso, Mariano R. Gabri

Original Research Article

Identification of Low-Level Product-Related Variants in Filgrastim Products Presently Available in Highly Regulated Markets

Anna Hausberger, William C. Lamanna, Martin Hartinger, Andreas Seidl, Hansjoerg Toll, Johann Holzmann